SCHEMBL7964670

SCHEMBL7964670

Cn1ccc2c(OC[C@H]3CO3)cccc21

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.53
GLA P06280 1/20 0.53
RHEB Q15382 1/20 0.48
TP53 P04637 3/20 0.44
TSHR P16473 3/20 0.44
HIF1A Q16665 2/20 0.44
CYP3A4 P08684 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
TDP1 Q9NUW8 1/20 0.41
PDK1 Q15118 1/20 0.39
NQO2 P16083 1/20 0.37
MAPT P10636 3/20 0.37
HPGD P15428 2/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
CYP1A2 P05177 1/20 0.37
PPARG P37231 1/20 0.37
LOXL2 Q9Y4K0 1/20 0.36
KDM4E B2RXH2 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4900717 1.00 ALDH1A1 (0.53) ALDH1A1GLARHEBTP53TSHR
SCHEMBL4900723 1.00 ALDH1A1 (0.53) ALDH1A1GLARHEBTP53TSHR
SCHEMBL9450134 0.86 ALDH1A1 (0.48) ALDH1A1GLARHEBTP53TSHR
SCHEMBL19089430 0.85 BRD4 (0.43) ALDH1A1RHEBTSHRTDP1PDK1
SCHEMBL9450004 0.83 TUBB4A (0.47) ALDH1A1GLARHEBPDK1TUBB4A
SCHEMBL9132470 0.80 SMN1; SMN2 (0.44) ALDH1A1GLATP53SMN1; SMN2MAPT
SCHEMBL729501 0.78 ALDH1A1 (0.65) ALDH1A1GLATP53TSHRHIF1A
SCHEMBL31668268 0.78 HTR6 (0.58) ALDH1A1GLATP53TSHRHIF1A
SCHEMBL4891775 0.75 ALDH1A1 (0.54) ALDH1A1GLATP53TSHRHIF1A
SCHEMBL4845719 0.75 MEN1 (0.53) MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6242450-B1 SUBSTITUTED PIPERIDINES ELI LILLY AND COMPANY 2001-06-05 US disclosed
WO-2000006082-A2 TREATMENT OF ANXIETY DISORDERS ELI LILLY AND COMPANY (US) 2000-02-10 WO disclosed
WO-2000006166-A1 5-HT1F ANTAGONISTS ELI LILLY AND COMPANY (US) 2000-02-10 WO disclosed
EP-0976746-A1 5-HT1F antagonists ELI LILLY AND COMPANY (US) 2000-02-02 EP disclosed
EP-0976747-A2 Use of 5HT-1F receptor antagonists for treating anxiety disorders ELI LILLY AND COMPANY (US) 2000-02-02 EP disclosed